ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Genzyme Corp. - Genzyme Corp. Common Stock (MM)

Genzyme Corp. - Genzyme Corp. Common Stock (MM) (GENZ)

76,25
0,00
(0,00%)
Fermé 19 Janvier 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
76,25
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
76,25
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

GENZ Dernières nouvelles

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation -- Company Announces Four-Day Subsequent Offer Period for Remaining Shareholders -- Genzyme Becomes a Subsidiary of...

Standard & Poor's Announces Change to U.S. Index

Standard & Poor's Announces Change to U.S. Index PR Newswire NEW YORK, March 29, 2011 NEW YORK, March 29, 2011 /PRNewswire/ -- BlackRock Inc. (NYSE: BLK) will replace Genzyme Corp. (NASD: GENZ...

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Corporation (NASDAQ: GENZ) announced today that its Board of Directors unanimously recommends that Genzyme shareholders accept the sanofi-aventis revised tender offer...

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Corporation (Nasdaq: GENZ) today announced that it has completed the sale of its pharmaceutical intermediates business to International Chemical Investors Group...

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Genzyme Corporation (NASDAQ: GENZ) today recognized International Rare Disease Day with the launch of a new program, the Genzyme Patient Advocacy Leadership Awards (PAL...

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Corporation (NASDAQ: GENZ) today announced three-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for...

Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year

Genzyme Corp. (NASDAQ: GENZ) today reported fourth-quarter 2010 results that reflect increasing supplies of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase...

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right Combination will enhance sanofi-aventis' sustainable growth strategy by expanding its...

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right -- Combination will enhance sanofi-aventis' sustainable growth strategy by expanding its footprint in...

Zacks Analyst Blog Highlights: Laboratory Corporation of America Holdings, Genzyme, Quest Diagnostics, Penn Virginia Resource Pa

Zacks Analyst Blog Highlights: Laboratory Corporation of America Holdings, Genzyme, Quest Diagnostics, Penn Virginia Resource Partners L.P. and Cloud Peak Energy PR Newswire CHICAGO, Feb. 11...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GENZ - Frequently Asked Questions (FAQ)

What is the current Genzyme share price?
The current share price of Genzyme is US$ 76,25
What is the 1 year trading range for Genzyme share price?
Genzyme has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock